Publicacións nas que colabora con Joan Bartra Tomás (49)

2024

  1. Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria

    Clinical and Experimental Allergy, Vol. 54, Núm. 6, pp. 402-411

2022

  1. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199

  2. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

  3. Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14

  4. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750

  5. Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens

    Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4

2021

  1. Aradyal: The spanish multidisciplinary research network for allergic diseases

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119

  2. Hypersensitivity reactions to cancer chemotherapy: Practical recommendations of aradyal for diagnosis and desensitization

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 5, pp. 364-384

  3. Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Adverse Drug Reactions and Allergy Network) Spanish allergy services

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. Diagnostic capacity of commercial extracts vs prick-by-prick in the study of sensitization to peanut: Which technique should we use?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 373-375

  2. Identification and Characterization of IgE-Reactive Proteins and a New Allergen (Cic a 1.01) from Chickpea (Cicer arietinum)

    Molecular Nutrition and Food Research, Vol. 64, Núm. 19

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Allergy rhinitis: Similarities and differences between children and adults

    Rhinology, Vol. 55, Núm. 4, pp. 326-331

  3. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144

  4. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

  2. Comparable actions of omalizumab on mast cells and basophils

    Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102

  3. Is the performance of ImmunoCAP ISAC 112 sufficient to diagnose peach and apple allergies?

    Annals of Allergy, Asthma and Immunology, Vol. 116, Núm. 2, pp. 162-163